用matrix-M,一种已经开发了几年的新佐剂,本来想用于流感疫苗

来源: fuz 2021-04-07 12:34:44 [] [博客] [旧帖] [给我悄悄话] 本文已被阅读: 次 (2173 bytes)
本文内容已被 [ fuz ] 在 2021-04-07 12:43:02 编辑过。如有问题,请报告版主或论坛管理删除.

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0041451

 

https://www.researchgate.net/publication/256200641_Matrix-M_adjuvant_Enhancing_immune_responses_by_%27setting_the_stage%27_for_the_antigen

 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899102/

 

https://pubmed.ncbi.nlm.nih.gov/29594879/

 

副作用,来自一、二期临试

https://www.biospace.com/article/novavax-s-covid-19-vaccine-shows-promise-in-phase-i/

The trial was conducted in healthy adults 18 to 59 years of age.

………、

The most common side effects were tenderness and pain after the first dose. Systemic side effects were less common, but were headache, fatigue and myalgia (achiness). There were generally more side effects reported after the second dose, although all were less than or equal to Grade 1. They lasted less than two days.

 

年过花甲的,別等了,赶紧打别的苗吧

 

 

所有跟帖: 

谢谢fuz. 很有用的信息。没有等疫苗,只是想也许以后会打加强针疫苗。novavax看着还不错,就是没有大规模使用有些副作用不清 -fxfz00- 给 fxfz00 发送悄悄话 fxfz00 的博客首页 (0 bytes) () 04/07/2021 postreply 12:55:01

请您先登陆,再发跟帖!